Reconstruction of Head and Neck Mucormycosis: A Literature Review and Own Experience in Immediate Reconstruction

Abstract

Background Mucormycosis is a rare invasive and fatal fungal infection. A prompt diagnosis is the most critical aspect for an improved patient outcome. Along with antifungal therapy, radical surgical debridement must be done expeditiously to eradicate this fungus. In this article, we evaluated the feasibility of immediate reconstruction after surgical debridement.

Methods A retrospective study was performed at Hospital Regional de Alta Especialidad de Ixtapaluca, Estado de México, Mexico, between June 2017 and June 2018. Five patients, three males and two females, with a mean age of 39 years were presented in addition to a literature review based on MEDLINE, Google Scholar, PubMed Central, and Embase platforms until June 2018.

Results From our presented series, all five flaps survived and showed no evidence of mucormycosis recurrence or flap loss. In the literature review, we collected 16 cases from 14 different publications of individuals with head and neck mucormycosis. Reconstruction was made with a free (12 cases) or pedicled flap (four cases). Eleven males and five females with a mean patient age of 33.0 years were studied. Only two authors described an early or immediate reconstruction. The average time of the delayed reconstruction after surgical debridement was 16.7 weeks.

Conclusion After aggressive surgical resection, immediate reconstruction can be done safely based on clinical criteria and as long as there is no evidence of hyphae invasion on wound edges in the intraoperative pathology examination.

Keywords

mucormycosis reconstruction - zygomycosis reconstruction - mucormycosis flap

• References

• 1 Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 2012; 54 (June, Suppl. 1): S23-S34
• 2 Roden MM, Zaoutis TE, Buchanan WL. , et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41 (05) 634-653
• 3 Fisher EW, Toma A, Fisher PH, Cheesman AD. Rhinocerebral mucormycosis: use of liposomal amphotericin B. J Laryngol Otol 1991; 105 (07) 575-577
• 4 Alleyne Jr CH, Vishteh AG, Spetzler RF, Detwiler PW. Long-term survival of a patient with invasive cranial base rhinocerebral mucormycosis treated with combined endovascular, surgical, and medical therapies: case report. Neurosurgery 1999; 45 (06) 1461-1463 , discussion 1463–1464
• 5 Lari AR, Kanjoor JR, Vulvoda M, Katchy KC, Khan ZU. Orbital reconstruction following sino-nasal mucormycosis. Br J Plast Surg 2002; 55 (01) 72-75
• 6 Tidwell J, Higuera S, Hollier Jr LH. Facial reconstruction after mucormycosis in an immunocompetent host. Am J Otolaryngol 2005; 26 (05) 333-336
• 7 Herford AS, Tandon R, Pivetti L, Cicciù M. Closure of large palatal defect using a tongue flap. J Craniofac Surg 2013; 24 (03) 875-877
• 8 Adler N, Seitz IA, Gottlieb LJ. Acute wound closure and reconstruction following head zygomycosis: presentation of two cases and review of literature. J Reconstr Microsurg 2008; 24 (07) 507-513
• 9 Metzen D, Böhm H, Zimmermann M, Reuther T, Kübler AC, Müller-Richter UDA. Mucormycosis of the head and neck. J Craniomaxillofac Surg 2012; 40 (08) e321-e327
• 10 Silberstein E, Krieger Y, Rosenberg N. , et al. Facial reconstruction of a mucormycosis survivor by free rectus abdominis muscle flap, tissue expansion, and ocular prosthesis. Ophthal Plast Reconstr Surg 2016; 32 (06) e131-e132
• 11 Augustine HFM, White C, Bain J. Aggressive combined medical and surgical management of mucormycosis results in disease eradication in 2 pediatric patients. Plast Surg (Oakv) 2017; 25 (03) 211-217
• 12 Bhatnagar A, Agarwal A. Naso-orbital fistula and socket reconstruction with radial artery forearm flap following orbital mucormycosis. Natl J Maxillofac Surg 2016; 7 (02) 197-200
• 13 Odessey E, Cohn A, Beaman K, Schechter L. Invasive mucormycosis of the maxillary sinus: extensive destruction with an indolent presentation. Surg Infect (Larchmt) 2008; 9 (01) 91-98
• 14 Antonetti J, Killyon GW, Chang P, McCauley RL. Microvascular transfer of burned tissue for mandibular reconstruction. J Burn Care Res 2009; 30 (03) 536-539
• 15 Shand JM, Albrecht RM, Burnett III HF, Miyake A. Invasive fungal infection of the midfacial and orbital complex due to Scedosporium apiospermum and mucormycosis. J Oral Maxillofac Surg 2004; 62 (02) 231-234
• 16 Ojeda-Uribe M, Herbrecht R, Kiefer MH. , et al. Lessons from a case of oromandibular mucormycosis treated with surgery and a combination of amphotericin B lipid formulation plus caspofungin. Acta Haematol 2010; 124 (02) 98-102
• 17 Murphy AD, Williamson PA, Vesely M. Reconstruction of an extensive peri-orbital defect secondary to mucormycosis in a patient with myelodysplasia. J Plast Reconstr Aesthet Surg 2013; 66 (03) e69-e71
• 18 Smith OJ, Pacifico M, Ross GL. Re: ‘The rectus sheath and serratus fascia “reverse” fashion flap for the coverage of the lower pole in immediate implant-based breast reconstruction’. J Plast Reconstr Aesthet Surg 2015; 68 (11) 1626-1627
• 19 Reinbold C, Derder M, Hivelin M, Ozil C, Al Hindi A, Lantieri L. Using free flaps for reconstruction during infections by mucormycosis: A case report and a structured review of the literature. Ann Chir Plast Esthet 2016; 61 (02) 153-161
• 20 Kyriopoulos EJ, Kyriakopoulos A, Karonidis A. , et al. Burn injuries and soft tissue traumas complicated by mucormycosis infection: a report of six cases and review of the literature. Ann Burns Fire Disasters 2015; 28 (04) 280-287
• 21 Moran SL, Strickland J, Shin AY. Upper-extremity mucormycosis infections in immunocompetent patients. J Hand Surg Am 2006; 31 (07) 1201-1205
• 22 Aggarwal S, Pennington D. Reconstruction of gluteal defects using free flaps. J Plast Reconstr Aesthet Surg 2013; 66 (08) 1149-1152
• 23 Danaei G, Finucane MM, Lu Y. , et al; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 2011; 378 (9785): 31-40
• 24 Meza R, Barrientos-Gutierrez TRojas-Martinez R. , et al. Burden of type 2 diabetes in Mexico: past, current and future prevalence and incidence rates. Prev Med 2015; 81: 445-450
• 25 Pagano L, Offidani M, Fianchi L. , et al; GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) Infection Program. Mucormycosis in hematologic patients. Haematologica 2004; 89 (02) 207-214
• 26 Hargrove RN, Wesley RE, Klippenstein KA, Fleming JC, Haik BG. Indications for orbital exenteration in mucormycosis. Ophthal Plast Reconstr Surg 2006; 22 (04) 286-291
• 27 Walsh TJ, Gamaletsou MN, Mcginnis MR, Hayden RT, Kontoyiannis DP. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). 2012; 54 (Suppl. 01) S55-S60
• 28 Cordeiro PG, Santamaria E. A classification system and algorithm for reconstruction of maxillectomy and midfacial defects. Plast Reconstr Surg 2000; 105 (07) 2331-2346 , discussion 2347–2348